Can a depression pill fight Cancer-Related appetite loss?
NCT ID NCT00488072
Summary
This study is testing whether a drug called mirtazapine, commonly used for depression, can help improve poor appetite and weight loss in people with advanced cancer. About 98 participants were randomly assigned to receive either mirtazapine or a placebo pill for two weeks, with researchers measuring changes in appetite, sleep, and other symptoms. The main goal is to see if the drug can meaningfully boost appetite scores after 15 days compared to a dummy pill.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANOREXIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.